Innovation Today, Healthier Tomorrows
November 4, 2016
Focus on prevention, early diagnosis, and innovative treatment options.
Chronic obstructive pulmonary disease or COPD affects over 24 million Americans and is the third leading cause of death in the United States. Since there remains no cure for COPD, the focus is on prevention, early diagnosis, and innovative treatment options to help patients manage the disease better. Although guidelines for the diagnosis and management of COPD currently exist, many clinicians may not be familiar with them or may not have implemented these guidelines in their practices yet. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) group has developed recommendations for COPD management. Patients and caregiver education is also a crucial part of a successful COPD treatment plan. Lifestyle changes, keeping up with changing symptoms and disease progression must be communicated effectively to the patient’s physician for successful symptom management. It’s also important for patients to be proactive when exacerbation occurs by keeping track and following up with their doctor.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.